Current laws and regulations are not enough to protect Americans from the risks of compounded versions of popular weight loss ...

Zepbound is a dual-activating medication that combines glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like ...

The U.S. FDA has released ... demonstrate sustained weight loss, which the agency defines as reduction in body fat for at least a year while on a maintenance dose of a medication.

A Bucks County woman is speaking out after her insurance company decided to no longer cover weight loss drugs.

Tirzepatide is the active ingredient in Zepbound, the FDA approved prescription medicine for Obstructive Sleep Apnea.

In a recent episode of the global health and wellness show Bloom, host Gayle Guyardo welcomed Dr. Bharti Shetye, MD, MFOMA, a ...

"Botox and fillers are not even FDA-approved for most of the places we use them," she noted. "Some individuals might start ...

In a rare move, the FDA recommended a minimum of 5% weight-loss for drug developers seeking to establish the efficacy of ...

Each brand has its own formula for helping users achieve their weight loss goals. Their methods include remote healthcare ...

Also in today’s edition: ‘no-show’ international student data and significant progress in Israel-Hamas ceasefire talks ...

Medicare now covers Eli Lilly's Zepbound for obstructive sleep apnea, FDA-approved for obesity and sleep apnea treatment, ...